Page last updated: 2024-10-18

dihydroxyphenylalanine and Anemia, Congenital Nonspherocytic Hemolytic

dihydroxyphenylalanine has been researched along with Anemia, Congenital Nonspherocytic Hemolytic in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beutler, E1

Other Studies

1 other study available for dihydroxyphenylalanine and Anemia, Congenital Nonspherocytic Hemolytic

ArticleYear
Genetic variability of G-6-PD.
    Humangenetik, 1970, Volume: 9, Issue:3

    Topics: Anemia, Hemolytic, Congenital Nonspherocytic; Dihydroxyphenylalanine; Favism; Genetic Variation; Glu

1970